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Dear Editor,
We sincerely appreciate the interest of Ferri et al. in our 
study and we are grateful for the valuable comments and 
feedback which have allowed us to respond with some clari-
fications [1]. The Letter to the Editor by Ferri et al. is merely 
focused on the timing of the tracheostomy, which actually 
is not the main aspect of the editorial letter by Mattioli et al. 
[2].
Ferri et al. suggested that tracheostomy should be per-
formed in stable or clinically improved patients affected by 
Coronavirus Disease 2019 (COVID-19), not before the 20th 
day after orotracheal intubation. The authors support the 
“late tracheostomy protocol” thesis on 8 patients undergoing 
open tracheostomy declaring a negative prognostic trend for 
the subgroup of patients with shorter duration of intubation. 
We deem it inappropriate to draw conclusion with such a 
small cohort of patients and without any data and expla-
nations regarding the reasons why an earlier tracheostomy 
would lead to worse survival.
Tracheostomy is one of the commonest surgical proce-
dure in the setting of acute respiratory distress syndrome 
(ARDS) with need of prolonged invasive mechanical venti-
lation (IMV). Traditionally, tracheostomies are performed to 
improve patient comfort, to facilitate airway and pulmonary 
toilet, to ease weaning and to facilitate the management of 
these patients. Moreover, it decreases the risk of complica-
tions such as subglottic and tracheal stenosis, which will 
likely become a striking reality amongst COVID-19 sur-
vivors (Mattioli et al.—under review). To date, one of the 
most convincing paper regarding this topic is the systematic 
review published by Adly et al. in 2018 [3]. The authors 
took into account 43 studies with a total number of 222,641 
patients, showing that early tracheostomy (performed within 
7 days from orotracheal intubation) reduces the clinical com-
plications (i.e. aspiration pneumonia, bacteremia, septic 
shock, multi-organ failure), the mortality rate as well as the 
length of stay in intensive care unit (ICU).
Although delaying tracheostomy for patients with 
COVID-19 might reduce risks for staff, extended duration 
of translaryngeal intubation, sedation, IMV, and ICU stay 
associated with such delays can lead to complications [4].
Moreover, an increased need for ICU admission due to 
COVID- 19-related ARDS was a reality at the time of the 
publication of Mattioli et al. editor letter [2]. The magnitude 
of this demand caused an imbalance between the real clini-
cal needs of the population and the effective availability of 
intensive resources. Thus, the tracheostomy represented an 
important measure for early ICU discharge to intermedi-
ate care ward for patients with ongoing IMV.  Recovering 
patients who continue to require ventilatory support via a 
tracheostomy can be managed with minimal sedation, which 
might simplify care and facilitate transfer to lower-acuity 
facilities, thus creating capacity for more acute patients. In 
accordance with recent expert’s guidelines [4], we deem 
appropriate that standard decision making should be adapted 
for the COVID-19 pandemic, taking into account a range of 
considerations, including potential risks and benefits for the 
individual patient; risks posed to health-care workers, other 
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patients, and family; and available health-care resources 
(Table 1). The timing of tracheostomy should consider 
patient’s clinical improvement perspective, which can be 
weighted through the Sequential Organ Failure Assessment 
(SOFA) score, as already stated in our previous Letter to the 
Editor and also demonstrated by other authors [5]. Although 
it is not possible to define an optimal timing, it is our opinion 
that tracheostomy should be indicated on case-by-case basis 
taking into account including potential risks and benefits for 
the individual patient; risks posed to health-care workers 
and other patients; and available health-care resources. In 
addition, we still deem appropriate to limit, when possible, 
late tracheostomies to avoid potential further complications.
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Table 1  Factors related to the 
tracheostomy decision making 
in COVID-19 epidemic
ICU Intensive Care Unit
Factors related to the tracheostomy in COVID-19 pandemic
Favors early tracheostomy Favors delayed tracheostomy
Maintenance of ICU capacity Potential risks to health-care 
workers, patients, and family
Pulmonary hygiene Multiorgan failure and prognosis
Laryngeal injury, trauma, or dysfunction Requirement for prone ventilation
Cumulative effects of sedation
Expedited participation in rehabilitation
Ventilator-associated pneumonia
Ventilator-associated respiratory muscle atrophy
Ability to communicate
